Download PDF
Neuropediatrics 2011; 42(1): 30-31
DOI: 10.1055/s-0031-1275738
Short Communication

© Georg Thieme Verlag KG Stuttgart · New York

Methylphenidate-Induced Visual Hallucinations

M. C. Porfirio1 , G. Giana1 , S. Giovinazzo1 , P. Curatolo1
  • 1Department of Neuroscience, Child Neurology Unit, Tor Vergata University, Rome, Italy
Further Information

Publication History

received 04.11.2010

accepted 24.03.2011

Publication Date:
15 April 2011 (online)

    Permissions and Reprints

Abstract

An 11-year-old boy with attention deficit/hyperactivity disorder (ADHD) presented with visual hallucinations several years after starting methylphenidate (MPH). The hallucinations resolved upon discontinuation of the drug. Reports of toxic hallucinosis during treatment with MPH are rare. Although the pathogenetic mechanism is unclear, the occurrence of hallucinations may be explained by a chronic increase in synaptic dopamine. Clinicians should be aware of this possible rare adverse manifestation occurring at therapeutic doses.

Key words

methylphenidate - hallucinations - ADHD

References

  • 1 Aguilera-Albesa S, Yoldi-Petri ME, Molins-Castiella T. et al . Alucinaciones tras la introducción de metilfenidato en dosis bajas [Hallucinations after methylphenidate introduction at low doses].  Rev Neurol. 2010;  51 254-255
    PubMedGoogle Scholar
  • 2 Cherland E, Fitzpatrick R. Psychotic side effects of psychostimulants: a 5-year review.  Can J Psychiatry. 1999;  44 811-813
    PubMedGoogle Scholar
  • 3 Curatolo P, Paloscia C, D’Agati E. et al . The neurobiology of attention deficit/hyperactivity disorder.  Eur J Paediatr Neurol. 2009;  13 299-304
    CrossrefPubMedGoogle Scholar
  • 4 Gross-Tzur V, Joseph A, Shalev RS. Hallucinations during methylphenidate therapy.  Neurology. 2004;  63 753-754
    PubMedGoogle Scholar
  • 5 Halevy A, Shuper A. Methylphenidate induction of complex visual hallucinations.  J Child Neurol. 2009;  24 1005-1007
    CrossrefPubMedGoogle Scholar
  • 6 Lucas A, Weiss M. Methyphenidate hallucinosis.  JAMA. 1971;  217 1079-1081
    CrossrefPubMedGoogle Scholar
  • 7 Rashid J, Mitelman S. Methylphenidate and somatic hallucinations.  J Am Acad Child Adolesc Psychiatry. 2007;  46 945-946
    CrossrefPubMedGoogle Scholar
  • 8 Ross R. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.  Am J Psychiatry. 2006;  1149-1152
    PubMedGoogle Scholar
  • 9 Tomas Vila M, Izquierdo Quevedo FJ, Cerdan Vera MT. et al . Alucinaciones visuales producidas por metilfenidato [Visual hallucinations caused by methylphenidate].  An Pediatr (Barc). 2010;  72 229-230
    CrossrefPubMedGoogle Scholar
  • 10 Wilens T, Pelham W, Stein M. et al . ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.  J Am Acad Child Adolesc Psychiatry. 2003;  42 424-433
    CrossrefPubMedGoogle Scholar
  • 11 Young JG. Methylphenidate-induced hallucinosis: case histories and possible mechanism of action.  J Dev Behav Pediatr. 1981;  35-38
    PubMedGoogle Scholar

Correspondence

Paolo Curatolo

Department of Neuroscience

Pediatric Neurology Unit

Tor Vergata University of Rome

via Montpellier 1

00133 Rome

Italy

Phone: + 39/06/41400 129

Fax: + 39/06/41400 343

Email: curatolo@uniroma2.it

      >